Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Clinical trial NCT00761215 · COMPLETED

Trial details

NCT number: NCT00761215
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Diseases, Infectious Skin Diseases, Bacterial

Start date: 2008-09-17
Primary completion: 2009-02-24
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.